Zenosense, Inc. (ZENO) Commences New Company Website

Today, Zenosense announced the launch of a new company website. Based in Valencia, Spain, Zenosense is a healthcare technology company engaging in the development and marketing of a detection device for use in hospitals and other healthcare settings. Zenosense’s device is being engineered to focus on detection of the Methicillin-resistant Staphylococcus aureus (MRSA) “Super-Bug”.

The new company website includes comprehensive details about Zenosense’s MRSA-detection device and its initiatives in its development, challenges for healthcare providers created by MRSA, and the device’s development team. SEC regulatory filings, news releases, stock performance, and other company-related information can be accessed there as well.

Zenosense looks to develop, market, and sell an effective MRSA detector, driven by the sizable costs associated with late detection of MRSA. The company seeks to provide a cost-efficient way for detecting MRSA in clinical settings, by route of in-licensed technology. Based on the costly consequences of late detection of MRSA, Zenosense believes that it has found a valuable new market segment for an effective, wearable detection device.

More information about Zenosense and its efforts can be found at the new website, located at: www.zenosense.net

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net